应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NXTC Nextcure Inc.
交易中 03-18 12:53:38 EDT
12.40
+0.08
+0.65%
最高
12.40
最低
12.03
成交量
1.53万
今开
12.32
昨收
12.32
日振幅
3.00%
总市值
4,415万
流通市值
2,550万
总股本
356.04万
成交额
18.74万
换手率
0.74%
流通股本
205.64万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Nextcure, Inc.盘中异动 临近收盘急速拉升6.06%报13.48美元
市场透视 · 03-12
Nextcure, Inc.盘中异动 临近收盘急速拉升6.06%报13.48美元
Nextcure, Inc.股价重挫16.82% 市值跌41.52万美元
市场透视 · 03-02
Nextcure, Inc.股价重挫16.82% 市值跌41.52万美元
Nextcure, Inc.盘中异动 股价大涨8.33%报11.84美元
市场透视 · 02-04
Nextcure, Inc.盘中异动 股价大涨8.33%报11.84美元
Nextcure, Inc.盘中异动 大幅下挫5.82%
市场透视 · 01-28
Nextcure, Inc.盘中异动 大幅下挫5.82%
Nextcure, Inc.盘中异动 股价大涨5.46%报14.10美元
市场透视 · 01-12
Nextcure, Inc.盘中异动 股价大涨5.46%报14.10美元
Nextcure, Inc.盘中异动 下午盘急速上涨5.32%
市场透视 · 2025-12-30
Nextcure, Inc.盘中异动 下午盘急速上涨5.32%
NextCure宣布按纳斯达克规则以市场价格进行2150万美元的普通股私募投资
美股速递 · 2025-11-12
NextCure宣布按纳斯达克规则以市场价格进行2150万美元的普通股私募投资
Nextcure, Inc.盘中异动 股价大跌6.70%报11.00美元
市场透视 · 2025-10-22
Nextcure, Inc.盘中异动 股价大跌6.70%报11.00美元
Nextcure与先声药业宣布Sim0505(Cdh6 ADC)正在进行的1期临床试验扩展至美国
美股速递 · 2025-10-16
Nextcure与先声药业宣布Sim0505(Cdh6 ADC)正在进行的1期临床试验扩展至美国
Nextcure, Inc.盘中异动 早盘急速下跌6.12%报6.24美元
市场透视 · 2025-10-13
Nextcure, Inc.盘中异动 早盘急速下跌6.12%报6.24美元
Nextcure, Inc.盘中异动 早盘股价大涨5.36%
市场透视 · 2025-10-10
Nextcure, Inc.盘中异动 早盘股价大涨5.36%
Nextcure, Inc.盘中异动 下午盘大幅跳水5.67%报5.42美元
市场透视 · 2025-09-26
Nextcure, Inc.盘中异动 下午盘大幅跳水5.67%报5.42美元
Nextcure, Inc.2024财年实现净利润-55.65百万美元,同比增加11.27%
市场透视 · 2025-03-10
Nextcure, Inc.2024财年实现净利润-55.65百万美元,同比增加11.27%
NextCure(NXTC.US):2024年Q4财报实现营收0美元,前值为0美元;每股收益为-0.41美元,前值为-0.52美元,预期值为-0.36美元。
金融界 · 2025-03-07
NextCure(NXTC.US):2024年Q4财报实现营收0美元,前值为0美元;每股收益为-0.41美元,前值为-0.52美元,预期值为-0.36美元。
NextCure 2024财年GAAP每股收益$(1.99)不及预期$(1.92)
财报速递 · 2025-03-07
NextCure 2024财年GAAP每股收益$(1.99)不及预期$(1.92)
Nextcure, Inc.盘中异动 早盘大幅上涨5.41%报0.780美元
市场透视 · 2025-03-07
Nextcure, Inc.盘中异动 早盘大幅上涨5.41%报0.780美元
Nextcure, Inc.盘中异动 大幅拉升5.53%报0.780美元
市场透视 · 2025-03-05
Nextcure, Inc.盘中异动 大幅拉升5.53%报0.780美元
Nextcure, Inc.盘中异动 快速下跌7.98%报0.671美元
市场透视 · 2025-03-05
Nextcure, Inc.盘中异动 快速下跌7.98%报0.671美元
Nextcure, Inc.盘中异动 下午盘股价大跌6.41%
市场透视 · 2025-03-04
Nextcure, Inc.盘中异动 下午盘股价大跌6.41%
Nextcure, Inc.盘中异动 股价大跌8.74%
市场透视 · 2025-02-28
Nextcure, Inc.盘中异动 股价大跌8.74%
加载更多
公司概况
公司名称:
Nextcure Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
NextCure, Inc.于2015年9月在特拉华州注册成立,总部位于马里兰州贝尔茨维尔。 该公司是一家临床阶段的生物制药公司,致力于发现和开发新型的一流免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。 通过其专有的功能性,集成式,免疫肿瘤学中的NextCure Discovery(“FIND-IO”)平台,公司研究各种免疫细胞,以发现和了解免疫细胞的靶标和结构成分及其功能影响,从而开发免疫组化。
发行价格:
--
{"stockData":{"symbol":"NXTC","market":"US","secType":"STK","nameCN":"Nextcure Inc.","latestPrice":12.4,"timestamp":1773852639853,"preClose":12.32,"halted":0,"volume":15257,"delay":0,"changeRate":0.006493506493506499,"floatShares":2056399,"shares":3560410,"eps":-19.646444,"marketStatus":"交易中","change":0.08,"latestTime":"03-18 12:53:38 EDT","open":12.32,"high":12.4,"low":12.03,"amount":187353.732478,"amplitude":0.030032,"askPrice":12.46,"askSize":116,"bidPrice":12.32,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-19.646444,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1773864000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1557374400000,"exchange":"NASDAQ","adjPreClose":12.32,"postHourTrading":{"tag":"盘后","latestPrice":12.32,"preClose":12.32,"latestTime":"16:10 EDT","volume":3,"amount":36.96,"timestamp":1773778204254,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.993102,"impliedVol":0.7756,"impliedVolPercentile":0.7875},"requestUrl":"/m/hq/s/NXTC","defaultTab":"news","newsList":[{"id":"2618909523","title":"Nextcure, Inc.盘中异动 临近收盘急速拉升6.06%报13.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618909523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618909523?lang=zh_cn&edition=full","pubTime":"2026-03-12 03:58","pubTimestamp":1773259100,"startTime":"0","endTime":"0","summary":"北京时间2026年03月12日03时58分,Nextcure, Inc.股票出现异动,股价大幅上涨6.06%。截至发稿,该股报13.48美元/股,成交量4.3323万股,换手率1.24%,振幅7.08%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为1.01%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312035820a461f3bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312035820a461f3bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0456854461.SGD","BK4139","LU0266512127.USD","CRC","BK4213","NXTC"],"gpt_icon":0},{"id":"2616350999","title":"Nextcure, Inc.股价重挫16.82% 市值跌41.52万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616350999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616350999?lang=zh_cn&edition=full","pubTime":"2026-03-02 22:38","pubTimestamp":1772462339,"startTime":"0","endTime":"0","summary":"北京时间2026年03月02日22时38分,Nextcure, Inc.股票出现异动,股价大幅下跌16.82%。截至发稿,该股报10.58美元/股,成交量1234股,换手率0.04%,振幅0.00%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为0.23%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030222390097a7af0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030222390097a7af0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NXTC","LU0266512127.USD","BK4213","CRC","LU0456854461.SGD"],"gpt_icon":0},{"id":"2608358502","title":"Nextcure, Inc.盘中异动 股价大涨8.33%报11.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608358502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608358502?lang=zh_cn&edition=full","pubTime":"2026-02-04 01:04","pubTimestamp":1770138295,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日01时04分,Nextcure, Inc.股票出现异动,股价快速拉升8.33%。截至发稿,该股报11.84美元/股,成交量1.2307万股,换手率0.35%,振幅4.21%。Nextcure, Inc.股票所在的生物技术行业中,整体涨幅为0.06%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020401045597a4b6fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020401045597a4b6fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","NXTC","CRC","BK4139","LU0456854461.SGD","LU0266512127.USD"],"gpt_icon":0},{"id":"2606132477","title":"Nextcure, Inc.盘中异动 大幅下挫5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606132477","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606132477?lang=zh_cn&edition=full","pubTime":"2026-01-28 04:02","pubTimestamp":1769544127,"startTime":"0","endTime":"0","summary":"北京时间2026年01月28日04时02分,Nextcure, Inc.股票出现异动,股价急速下跌5.82%。Nextcure, Inc.股票所在的生物技术行业中,整体涨幅为0.64%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012804020897a3a6f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012804020897a3a6f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXTC","LU0456854461.SGD","BK4213","CRC","LU0266512127.USD","BK4139"],"gpt_icon":0},{"id":"2603291565","title":"Nextcure, Inc.盘中异动 股价大涨5.46%报14.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603291565","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603291565?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:35","pubTimestamp":1768228518,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时35分,Nextcure, Inc.股票出现波动,股价大幅上涨5.46%。截至发稿,该股报14.10美元/股,成交量193股,换手率0.01%,振幅0.00%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为1.19%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223518a4bb11d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223518a4bb11d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXTC","LU0456854461.SGD","CRC","BK4139","BK4213","LU0266512127.USD"],"gpt_icon":0},{"id":"2595179222","title":"Nextcure, Inc.盘中异动 下午盘急速上涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595179222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595179222?lang=zh_cn&edition=full","pubTime":"2025-12-30 03:31","pubTimestamp":1767036698,"startTime":"0","endTime":"0","summary":"北京时间2025年12月30日03时31分,Nextcure, Inc.股票出现波动,股价急速拉升5.32%。截至发稿,该股报13.45美元/股,成交量1.6169万股,换手率0.46%,振幅5.32%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为0.68%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230033138a4871b8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230033138a4871b8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRC","LU0456854461.SGD","BK4139","NXTC","LU0266512127.USD","BK4213"],"gpt_icon":0},{"id":"1195873990","title":"NextCure宣布按纳斯达克规则以市场价格进行2150万美元的普通股私募投资","url":"https://stock-news.laohu8.com/highlight/detail?id=1195873990","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195873990?lang=zh_cn&edition=full","pubTime":"2025-11-12 21:01","pubTimestamp":1762952473,"startTime":"0","endTime":"0","summary":"NextCure宣布按纳斯达克规则以市场价格进行2150万美元的普通股私募投资","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NXTC"],"gpt_icon":0},{"id":"2577301174","title":"Nextcure, Inc.盘中异动 股价大跌6.70%报11.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577301174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577301174?lang=zh_cn&edition=full","pubTime":"2025-10-22 21:46","pubTimestamp":1761140817,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日21时46分,Nextcure, Inc.股票出现波动,股价急速跳水6.70%。截至发稿,该股报11.00美元/股,成交量7758股,换手率0.29%,振幅4.95%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为0.03%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022214657973cba27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022214657973cba27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4213","NXTC","CRC","BK4007","BK4139","LU0456854461.SGD","LU0266512127.USD"],"gpt_icon":1},{"id":"1161819600","title":"Nextcure与先声药业宣布Sim0505(Cdh6 ADC)正在进行的1期临床试验扩展至美国","url":"https://stock-news.laohu8.com/highlight/detail?id=1161819600","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161819600?lang=zh_cn&edition=full","pubTime":"2025-10-16 20:07","pubTimestamp":1760616433,"startTime":"0","endTime":"0","summary":"Nextcure与先声药业宣布Sim0505(Cdh6 ADC)正在进行的1期临床试验扩展至美国","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096","BK1583","BK1191","BK4139","NXTC"],"gpt_icon":0},{"id":"2575823365","title":"Nextcure, Inc.盘中异动 早盘急速下跌6.12%报6.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575823365","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575823365?lang=zh_cn&edition=full","pubTime":"2025-10-13 21:33","pubTimestamp":1760362397,"startTime":"0","endTime":"0","summary":"北京时间2025年10月13日21时33分,Nextcure, Inc.股票出现波动,股价急速跳水6.12%。截至发稿,该股报6.24美元/股,成交量1565股,换手率0.06%,振幅2.11%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为0.46%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013213317a6b731c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013213317a6b731c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","LU0456854461.SGD","LU0266512127.USD","CRC","NXTC","BK4139"],"gpt_icon":0},{"id":"2574926439","title":"Nextcure, Inc.盘中异动 早盘股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574926439","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574926439?lang=zh_cn&edition=full","pubTime":"2025-10-10 22:14","pubTimestamp":1760105671,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日22时14分,Nextcure, Inc.股票出现异动,股价急速拉升5.36%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为0.26%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510102214319726ae20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510102214319726ae20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4213","LU0456854461.SGD","CRC","NXTC","LU0266512127.USD"],"gpt_icon":0},{"id":"2570078561","title":"Nextcure, Inc.盘中异动 下午盘大幅跳水5.67%报5.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570078561","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570078561?lang=zh_cn&edition=full","pubTime":"2025-09-26 02:31","pubTimestamp":1758825101,"startTime":"0","endTime":"0","summary":"北京时间2025年09月26日02时31分,Nextcure, Inc.股票出现异动,股价快速跳水5.67%。截至发稿,该股报5.42美元/股,成交量919股,换手率0.03%,振幅4.00%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为1.09%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092602314195453089&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092602314195453089&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0266512127.USD","BK4139","NXTC","LU0456854461.SGD","BK4213","CRC"],"gpt_icon":0},{"id":"2518284977","title":"Nextcure, Inc.2024财年实现净利润-55.65百万美元,同比增加11.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518284977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518284977?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536082,"startTime":"0","endTime":"0","summary":"3月10日,Nextcure, Inc.公布财报,公告显示公司2024财年净利润为-55.65百万美元,同比增加11.27%;其中营业收入为0.00美元,每股基本收益为-1.99美元。从资产负债表来看,Nextcure, Inc.总负债16.45百万美元,其中短期债务796000.00美元,资产负债比为4.98,流动比率为7.51。机构评级:截至2025年3月10日,当前有2家机构对Nextcure, Inc.目标价做出预测,其中目标均价为3.00美元,其中最低目标价为3.00美元,最高目标价为3.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000304a2689894&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000304a2689894&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXTC"],"gpt_icon":0},{"id":"2517145291","title":"NextCure(NXTC.US):2024年Q4财报实现营收0美元,前值为0美元;每股收益为-0.41美元,前值为-0.52美元,预期值为-0.36美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517145291","media":"金融界","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517145291?lang=zh_cn&edition=full","pubTime":"2025-03-07 06:57","pubTimestamp":1741301839,"startTime":"0","endTime":"0","summary":"NextCure(NXTC.US):2024年Q4财报实现营收0美元,前值为0美元;每股收益为-0.41美元,前值为-0.52美元,预期值为-0.36美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07065748578832.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NXTC"],"gpt_icon":0},{"id":"1113678994","title":"NextCure 2024财年GAAP每股收益$(1.99)不及预期$(1.92)","url":"https://stock-news.laohu8.com/highlight/detail?id=1113678994","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113678994?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:19","pubTimestamp":1741295952,"startTime":"0","endTime":"0","summary":"NextCure(NASDAQ:NXTC)报告季度每股亏损$(1.99),低于分析师一致预期$(1.92),差幅为3.65%。以上内容来自Benzinga Earnings专栏,原文如下:NextCure (NASDAQ:NXTC) reported quarterly losses of $(1.99) per share which missed the analyst consensus estimate of $(1.92) by 3.65 percent.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"NextCure 2024财年GAAP每股收益$(1.99)不及预期$(1.92)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC"],"gpt_icon":0},{"id":"2517167564","title":"Nextcure, Inc.盘中异动 早盘大幅上涨5.41%报0.780美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517167564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517167564?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:04","pubTimestamp":1741277091,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时04分,Nextcure, Inc.股票出现异动,股价快速上涨5.41%。截至发稿,该股报0.780美元/股,成交量2.2204万股,换手率0.08%,振幅4.36%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为0.38%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000451abeb8e07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000451abeb8e07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRC","LU0456854461.SGD","BK4139","NXTC","LU0266512127.USD","BK4213"],"gpt_icon":0},{"id":"2517943623","title":"Nextcure, Inc.盘中异动 大幅拉升5.53%报0.780美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517943623","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517943623?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:49","pubTimestamp":1741186149,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时49分,Nextcure, Inc.股票出现波动,股价急速上涨5.53%。截至发稿,该股报0.780美元/股,成交量770股,换手率0.00%,振幅0.00%。Nextcure, Inc.股票所在的生物技术行业中,整体涨幅为1.51%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224909963ae0f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224909963ae0f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NXTC","BK4213","CRC","LU0456854461.SGD","LU0266512127.USD"],"gpt_icon":0},{"id":"2517067216","title":"Nextcure, Inc.盘中异动 快速下跌7.98%报0.671美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517067216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517067216?lang=zh_cn&edition=full","pubTime":"2025-03-05 00:09","pubTimestamp":1741104554,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日00时09分,Nextcure, Inc.股票出现波动,股价大幅下跌7.98%。截至发稿,该股报0.671美元/股,成交量1.0797万股,换手率0.04%,振幅5.49%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为0.41%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030500091496395e97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030500091496395e97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","LU0266512127.USD","NXTC","BK4139","CRC","LU0456854461.SGD"],"gpt_icon":0},{"id":"2516668245","title":"Nextcure, Inc.盘中异动 下午盘股价大跌6.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516668245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516668245?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:31","pubTimestamp":1741030270,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时31分,Nextcure, Inc.股票出现异动,股价大幅下跌6.41%。截至发稿,该股报0.729美元/股,成交量6210股,换手率0.02%,振幅4.49%。Nextcure, Inc.股票所在的生物技术行业中,整体涨幅为0.55%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304033111989a519e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304033111989a519e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRC","NXTC","BK4213","LU0456854461.SGD","LU0266512127.USD","BK4139"],"gpt_icon":0},{"id":"2514200733","title":"Nextcure, Inc.盘中异动 股价大跌8.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514200733","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514200733?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:33","pubTimestamp":1740753228,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时33分,Nextcure, Inc.股票出现异动,股价大幅下挫8.74%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为0.12%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段生物制药公司,致力于发现和开发新型,一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223349963419e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223349963419e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0266512127.USD","BK4139","NXTC","LU0456854461.SGD","BK4213","CRC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nextcure.com","stockEarnings":[{"period":"1week","weight":-0.0307},{"period":"1month","weight":-0.0595},{"period":"3month","weight":0.1722},{"period":"6month","weight":1.178},{"period":"1year","weight":0.6029},{"period":"ytd","weight":-0.1318}],"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0161},{"period":"3month","weight":-0.0009},{"period":"6month","weight":0.0129},{"period":"1year","weight":0.1827},{"period":"ytd","weight":-0.0163}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NextCure, Inc.于2015年9月在特拉华州注册成立,总部位于马里兰州贝尔茨维尔。 该公司是一家临床阶段的生物制药公司,致力于发现和开发新型的一流免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。 通过其专有的功能性,集成式,免疫肿瘤学中的NextCure Discovery(“FIND-IO”)平台,公司研究各种免疫细胞,以发现和了解免疫细胞的靶标和结构成分及其功能影响,从而开发免疫组化。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":-0.02663},{"month":2,"riseRate":0.285714,"avgChangeRate":0.046168},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.05862},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.143583},{"month":5,"riseRate":0.5,"avgChangeRate":0.044182},{"month":6,"riseRate":0.571429,"avgChangeRate":-0.038185},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.066636},{"month":8,"riseRate":0.571429,"avgChangeRate":0.058864},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.085295},{"month":10,"riseRate":0.428571,"avgChangeRate":0.136079},{"month":11,"riseRate":0.571429,"avgChangeRate":0.061609},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.021792}],"exchange":"NASDAQ","name":"Nextcure Inc.","nameEN":"Nextcure Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nextcure Inc.(NXTC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nextcure Inc.(NXTC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nextcure Inc.,NXTC,Nextcure Inc.股票,Nextcure Inc.股票老虎,Nextcure Inc.股票老虎国际,Nextcure Inc.行情,Nextcure Inc.股票行情,Nextcure Inc.股价,Nextcure Inc.股市,Nextcure Inc.股票价格,Nextcure Inc.股票交易,Nextcure Inc.股票购买,Nextcure Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nextcure Inc.(NXTC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nextcure Inc.(NXTC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}